The Association of Biochemical and Genetic Biomarkers in VEGF Pathway with Depression
Open Access
- 9 December 2022
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 14 (12), 2757
- https://doi.org/10.3390/pharmaceutics14122757
Abstract
VEGF is an important neurotrophic and vascular factor involved in mental disorders. The objective of this study was to verify the effect of genetic polymorphisms in the VEGF pathway on the risk for depression, symptom intensity, and suicide attempts. To examine the association between the VEGF pathway and depression, we genotyped polymorphisms and measured the plasma concentrations of VEGF, KDR, and FLT1 proteins. The participants were 160 patients with depression and 114 healthy controls. The questionnaires that assessed the clinical profile of the patients were the MINI-International Neuropsychiatric Interview, GRID-HAMD21, CTQ, BSI, and the number of suicide attempts. Genotyping of participants was performed using the real-time PCR and protein measurements were performed using the enzyme-linked immunosorbent assay (ELISA). VEGF and its inhibitors were reduced in depression. Individuals with depression and displaying the homozygous AA of the rs699947 polymorphism had higher plasma concentrations of VEGF (p-value = 0.006) and were associated with a greater number of suicide attempts (p-value = 0.041). Individuals with depression that were homozygous for the G allele of the FLT1 polymorphism rs7993418 were associated with lower symptom severity (p-value = 0.040). Our results suggest that VEGF pathway polymorphisms are associated with the number of suicide attempts and the severity of depressive symptoms.Keywords
Funding Information
- São Paulo Research Foundation (#2018/18312-2)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (01)
- National Council for Scientific and Technological Development (#440579/2014-7, 302898/2020-4)
This publication has 78 references indexed in Scilit:
- Attenuation of VEGFR-2 Expression by sFlt-1 and Low Oxygen in Human PlacentaPLOS ONE, 2013
- Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010The Lancet, 2013
- Immature Dentate Gyrus: An Endophenotype of Neuropsychiatric DisordersNeural Plasticity, 2013
- Functional Biomarkers of Depression: Diagnosis, Treatment, and PathophysiologyNeuropsychopharmacology, 2011
- Mast Cells as Early Responders in the Regulation of Acute Blood–Brain Barrier Changes after Cerebral Ischemia and HemorrhageJournal of Cerebral Blood Flow & Metabolism, 2010
- Monocyte Chemotactic Protein-1 (MCP-1) and Growth Factors Called into Question as Markers of Prolonged Psychosocial StressPLOS ONE, 2009
- S100B's double life: Intracellular regulator and extracellular signalBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2009
- VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdownProceedings of the National Academy of Sciences of the United States of America, 2009
- Vascular Endothelial Growth Factor and AngiogenesisPharmacological Reviews, 2004
- Hypoxia-inducible factor (HIF-1)α: its protein stability and biological functionsExperimental & Molecular Medicine, 2004